Skip to main content

Table 1 Characteristics of study groups

From: Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model

Group Primary (1st, 2nd) vaccine Booster vaccine
Negative control Saline Saline
Positive control DTaP from GC pharma Commercially available Tdap
GC3111 DTaP from GC pharma GC3111 Tdap produced in 2010
Enhanced GC3111 DTaP from GC pharma GC3111 Tdap FHA enhanced
  1. DTaP = diphtheria-tetanus-acellular pertussis, GC Pharma = Green Cross Pharma, Tdap = tetanus-reduced dose diphtheria-acellular pertussis, FHA = filamentous hemagglutinin